药品招标采购中质量分层机制的评价研究  

Study on the Evaluation of Quality Layering Mechanism in Drug Bidding Procurement

作　　者：汤少梁[1] 张玉蓉[1] 

机构地区：[1]南京中医药大学经贸管理学院,江苏南京210004

出　　处：《中国执业药师》2014年第8期36-40,56,共6页China Licensed Pharmacist

基　　金：2011年度教育部人文社会科学研究项目(11YJA630112);江苏省社会科学基金项目(07SJD630061);2012年度江苏省高校"青蓝工程"资助成果

摘　　要：现行药品招标采购活动中采用的质量分层已经不能实现其预期的作用,不仅达不到对药品质量进行层次区分的目的,反而成为部分品种维护和提高价格、部分地区实施地方保护主义的保护伞。本文以招标采购中药品的质量分层机制为研究对象,基于博弈论分析质量分层机制的必要性,以基本药物招标采购为例,分析药品质量分层出现的问题及原因,并在此基础上探讨药品质量分层机制的优化策略。The current quality layering system adopted in the essential drug bidding procurement has not showed an effective role as expected. It failed to realize the purpose of distinguishing drug quality,but functioned as a protective umbrella to maintain or raise the drug price of part of varieties and to implement local protectionism. In this article the drug quality layering mechanism used in drug bidding procurement was made as the study subject and its importance was analyzed according to game theory. With the example of essential drug bidding procurement,problems and the reasons occurred in drug quality layering mechanism were analyzed,and on this basis the optimization strategy was explored.

关 键 词：药品招标 博弈论 质量分层 评价 

分 类 号：R954[医药卫生—药学]